Sign in
4

Changes in Ownership

Foghorn Therapeutics Inc. Filed Acc 0000899243-20-031581

Options or other derivatives

  • Chief Legal Officer acquired 162,162 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
LaCascia Michael Chief Legal Officer 2020-11-17 Grant or award · Stock Option (Right to Buy) +162,162 162,162 D
Loading xslF345X03/doc4.xml…